Tran, J. Q., Zhang, P., Walker, S., Ghosh, A., Syto, M., Wang, X., . . . Palmisano, M. (2020). Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects. Advances in therapy, 37(12), 4944-4958. https://doi.org/10.1007/s12325-020-01500-0
Chicago Style (17th ed.) CitationTran, Jonathan Q., Peijin Zhang, Susan Walker, Atalanta Ghosh, Mary Syto, Xiaomin Wang, Sarah Harris, and Maria Palmisano. "Multiple-Dose Pharmacokinetics of Ozanimod and Its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects." Advances in Therapy 37, no. 12 (2020): 4944-4958. https://doi.org/10.1007/s12325-020-01500-0.
MLA (9th ed.) CitationTran, Jonathan Q., et al. "Multiple-Dose Pharmacokinetics of Ozanimod and Its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects." Advances in Therapy, vol. 37, no. 12, 2020, pp. 4944-4958, https://doi.org/10.1007/s12325-020-01500-0.